Search
+
    SEARCHED FOR:

    HEART SURGERY

    These large- and mid-cap stocks can give more than 25% return in 1 year, according to analysts

    Over the next few days, as an investor you need to make a clear distinction on one front: Buying happening in a sector at a lower level, and short covering. Why? Because short covering-led upmoves don't sustain. Also remember: Whether an upmove in the broader market will sustain or not also depends on how the Q4 earnings season pans out. As of now, no major trouble spots have emerged.

    For investors with ability to think beyond FY27: 5 mid-cap stocks from different sectors with an upside potential up to 33%

    The US blockade of the Strait of Hormuz, a claim by President Trump that negotiations are not dead in the water, and some tough talk from Iran. Together they ensured that confusion reigned over the fate of the Gulf war, with each cue impacting markets and crude oil prices in different ways. So, uncertainty is still the dominant theme for global markets. But then stock prices have also corrected, so the current situation presents opportunities as well.

    These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%

    It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global economy. But remember this: Whatever its intensity or length, there is enough historical evidence to show that markets have a greater probability of trading at a higher level a few months after a war. And no war in the Gulf has dragged on. So, all one needs is patience – and the ability to think beyond the war.

    Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?

    A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a potential breakthrough for diabetes and obesity. Experts believe it could also contribute to longevity goals. Clinical trials show significant weight loss. Retatrutide's unique triple-action mechanism sets it apart from existing treatments, promising a new era in metabolic health management.

    Manage short-term risk and volatility for long-term opportunity: 7 stocks from different sectors with upside potential of up to 32%

    There will be many ifs and buts – and a high volatility quotient – when a market is in its initial phase of correction, especially a correction caused by a mix of many reasons. We will only know a bottom has been formed much after it has been formed. And anyone who claims they know when and where the bottom will be formed will most likely be proven wrong. So, rather than thinking about where the Nifty or the Sensex will be at the end of this phase of correction, focus on what to look for in the midst of the volatility.

    Tiny hearts, big cardiac concern in India

    A screening program in Raipur, Chhattisgarh, has found over 100 children with heart defects. Sixteen have undergone surgery, with more planned. This initiative, Project Dhadkan, aims to detect hidden heart risks early. Experts estimate many Indian children are born with such conditions. Early detection and treatment are crucial for normal lives. The program offers free screening and surgeries.

    The Economic Times
    BACK TO TOP